Lynn Malec

Venous thromboembolism in pediatric trauma patients: Ten‐year experience and long‐term follow‐up in a tertiary care center

Christine M. Leeper, Madhav Vissa, James Cooper et al. · Pediatric Blood & Cancer · 2017 · 47 citations

Regional variation and cost implications of prescribed extended half‐life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia

Stacy E. Croteau, Dunlei Cheng, Alice J. Cohen et al. · Haemophilia · 2019 · 43 citations

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Margaret V. Ragni, Scott D. Rothenberger, Robert Feldman et al. · The Lancet Haematology · 2023 · 34 citations · Full text

Thrombosis, Hematology, Gynecology +8

The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States

Lynn Malec, Dunlei Cheng, Char Witmer et al. · American Journal of Hematology · 2020 · 31 citations · Full text

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Lynn Malec, Stacy E. Croteau, Michael U. Callaghan et al. · Haemophilia · 2020 · 26 citations

Thrombosis, Laboratory Hematology, Blood Transfusion +10